Skip to main content
. 2019 Jan 28;7(1):12. doi: 10.3390/vaccines7010012

Table 3.

Mean clinical and pathological scores post challenge with ASFV Armenia 2007.

Scores dpc Group 1 Group 2 Group 3
Observed clinical score 0 0.0 ± 0.00 0.5 ± 0.71 0.8 ± 0.45
1 0.0 ± 0.00 1.0 ± 1.41 0.8 ± 1.10
2 0.0 ± 0.00 0.5 ± 0.71 1.0 ± 1.22
3 0.7 ± 0.58 2.0 ± 2.83 1.0 ± 1.00
4 1.7 ± 0.58 4.5 ± 0.71* 1.2 ± 0.84*
5 2.67 ± 2.08 9.5 ± 0.71* 3.4 ± 1.95*
6 10.33 ± 3.51 na 6.4 ± 3.58
7 25.67 ± 10.97 na 15.2 ± 9.52
8 na na 28.8 ± 7.16
Gross pathological score 5–8 29.7 ± 9.87 31.5 ± 7.78 18.6 ± 13.94
Histopathological score 5–8 62.2 ± 10.77 66 ± 9.90 57.9 ± 19.32

Mean ± standard deviation (SD); dpc = days post challenge; na = no surviving animals. Clinical and pathological scoring details are provided in supplementary Tables S1 and S2. Significance found between Groups 2 and 3 clinical scores at days 4 and 5 (*; p-values of 0.004 and 0.009, respectively). Statistical significance was determined by multiple comparison t test using the Holm-Sidak method, with alpha = 5.000%, and each row analyzed individually, without assuming a consistent SD.